Kine Sciences Co., Ltd.

This was a small, early-stage study to check if a new drug called KINE-101 is safe for people with a chronic nerve disease called CIDP, when standard steroid treatments haven't worked. Nine patients received a single intravenous dose at one of three increasing levels and were mon…

This early-stage study tested a new drug called KINE-101 in 24 healthy volunteers to see if it's safe and how it behaves in the body. Participants received daily intravenous doses for one week at three different strength levels, while some received a placebo. The main goal was to…

This is the first study to test a new drug called KINE-101 in humans. It enrolled 40 healthy volunteers to check if the drug is safe and to see how the body absorbs and processes it. Participants received either the drug or a placebo (inactive substance) as a single injection or …